Empresas y finanzas

2007 BIO International Convention Attendees Join Voters, Biotech Execs In Optimism About Finding Cures to Diseases



    Attendees at the 2007 BIO International Convention joined voters
    and high-level biotechnology executives in expressing a strong sense
    of optimism about the possibility that the biotechnology industry will
    be able to find a cure for serious diseases like Parkinson's Disease,
    HIV/AIDS and cancer over the next 10 to 15 years.

    More than 1,800 conference attendees participated in an online
    survey exploring a set of key biotechnology issues during the BIO
    International Convention held this week in Boston. The poll follows
    two similar parallel surveys comparing the views of nationwide voters
    and senior-level biotechnology executives on a number of issues,
    including health care, the environment, alternative fuels and stem
    cell research.

    All three polls were conducted by nationally recognized Republican
    and Democratic strategy firms Public Opinion Strategies and Peter D.
    Hart Research Associates.

    "I'm excited to see that voters, convention attendees and industry
    leaders all share the same optimistic view of the future of
    biotechnology," said Jim Greenwood, president and CEO of the
    Biotechnology Industry Organization (BIO), the producer of the
    International Convention. "We now need to work together to ensure that
    we have the right public policy and regulatory framework in place to
    make this optimism a reality."

    The survey also found that attendees, like voters, rate the
    importance of finding cures to diseases as a top national issue (71%
    and 78% respectively,) ahead of combating terrorism, addressing
    illegal immigration and protecting the environment.

    Industry leaders, convention attendees and voters all have high
    levels of optimism about the potential for finding cures for serious
    diseases. Industry leaders expressed a strong sense of confidence that
    this problem could be solved, with 94 percent saying they were
    optimistic about the potential for finding cures to serious diseases,
    compared to 86 percent of voters and 86 percent of Convention
    attendees.

    Meanwhile, Convention attendees and voters both have higher
    expectations than industry leaders on the likelihood of achieving
    energy independence, reducing pollution and eliminating hunger and
    malnutrition. Thirty-nine percent of voters rated attaining energy
    independence among the top one or two most likely biotechnology
    achievements, Convention attendees were right in the middle with 26
    percent, while only 17 percent of the top-level executives interviewed
    rated achieving energy independence among the top one or two most
    likely goals the industry would achieve over the next 10 to 15 years.

    This research project, consistent with the theme of this year's
    BIO International Convention, "New Ideas. Bold Ventures. Global
    Benefits," encompassed the results of three separate surveys. A
    national telephone survey of 800 registered voters was conducted April
    17-19, 2007. A national Internet survey of 252 biotechnology industry
    leaders was conducted April 11-24, 2007. Finally, an Internet survey
    was completed by 1,859 BIO International Convention attendees. This
    survey was conducted May 6-9, 2007, during the Convention.

    More information on the first two polls conducted by Public
    Opinion Strategies and Peter D. Hart Research Associates, please go to
    http://www.bio2007.org/Media/pr2.asp?id=2007_0506_01. Summaries and
    data from of all three polls are available at
    http://bio2007.org/Attendees/Sun01.html

    About BIO

    Founded in 1993, BIO represents more than 1,100 biotechnology
    companies, academic institutions, state biotechnology centers and
    related organizations across the United States and 31 other nations.
    BIO members are involved in the research and development of
    health-care, agricultural, industrial and environmental biotechnology
    products. BIO also produces the annual BIO International Convention,
    the world's largest annual gathering of the global biotechnology
    industry. www.bio.org

    About Public Opinion Strategies

    Public Opinion Strategies is a survey research company
    specializing in corporate, public policy and litigation research, with
    offices in Washington, Denver and Los Angeles. Since its founding in
    1991, Public Opinion Strategies has completed more than 10,000
    research projects and interviewed more than four million Americans
    across the United States. These projects have ranged in scope from
    neighborhood studies to national samples in all 50 states.
    Internationally, Public Opinion Strategies has completed research
    projects in Albania, Australia, Bulgaria, Canada, Guam, Israel, Kenya,
    Mexico, Mongolia, Montenegro, New Zealand, Poland, Russia, Serbia,
    Venezuela, South Africa, and the United Kingdom. Since Public Opinion
    Strategies' roots are in political campaign management, their research
    is focused on producing information that compels decisions - and then
    results.

    About Peter D. Hart Research Associates

    Founded in 1971, Peter D. Hart Research Associates is one of the
    leading survey research firms in the United States and has been at the
    cutting edge of change in the field of public opinion for more than
    three decades. In that time, we have conducted well over 5,000 public
    opinion surveys and have administered and analyzed interviews among
    more than three million individuals. We have also undertaken more than
    5,000 focus group sessions.

    -0-
    *T
    Upcoming BIO Events

    -- BIO VentureForum-East 2007
    June 18-20, 2007
    Montreal, Canada

    -- BIO Mid-America VentureForum 2007
    Sep. 24-26, 2007
    Milwaukee, WI
    *T